Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Indicadores sociales
2
Administración
1
Antropología forense
1
Calidad de vida
1
Capital humano
1
Comportamiento organizacional
1
Comunidades indígenas
1
Condiciones sociales
1
Desarrollo sostenible
1
Educación inclusiva
1
Educación superior
1
Estudiantes con discapacidades
1
Exhumación
1
Filosofía de la tecnología
1
Identificación
1
Liderazgo
1
Minorías
1
Muerte
1
Mujeres
1
Personas desaparecidas
1
Realidad virtual
1
-
221“…Initial management involves maximising surgical resection while preserving neurologic function. IDH mutations and MGMT promoter methylation should be checked in tumour samples. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
222por Chen, Xueqin, Liu, Jun, Li, Yuqin, Zeng, Yuequan, Wang, Fang, Cheng, Zexiong, Duan, Hao, Pan, Guopeng, Yang, Shangqi, Chen, Yuling, Li, Qing, Shen, Xi, Li, Ying, Qin, Zixi, Chen, Jiahong, Huang, Youwei, Wang, Xiangyu, Lu, Yuli, Shu, Minfeng, Zhang, Yubo, Wang, Guocai, Li, Kai, Lin, Xi, Xing, Fan, Zhang, Haipeng“…IDH1 mutations frequently occur early in human glioma. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
223por Rautajoki, Kirsi J., Jaatinen, Serafiina, Hartewig, Anja, Tiihonen, Aliisa M., Annala, Matti, Salonen, Iida, Valkonen, Masi, Simola, Vili, Vuorinen, Elisa M., Kivinen, Anni, Rauhala, Minna J., Nurminen, Riikka, Maass, Kendra K., Lahtela, Sirpa-Liisa, Jukkola, Arja, Yli-Harja, Olli, Helén, Pauli, Pajtler, Kristian W., Ruusuvuori, Pekka, Haapasalo, Joonas, Zhang, Wei, Haapasalo, Hannu, Nykter, Matti“…In this project, we analyzed matched IDH-mutant astrocytomas before and after progression to grade 4 from six patients (discovery cohort) with genome-wide sequencing, 21 additional patients with targeted sequencing, and 33 patients from Glioma Longitudinal AnalySiS cohort for validation. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
224por Choi, Changho, Ganji, Sandeep K., DeBerardinis, Ralph J., Hatanpaa, Kimmo J., Rakheja, Dinesh, Kovacs, Zoltan, Yang, Xiao-Li, Mashimo, Tomoyuki, Raisanen, Jack M., Marin-Valencia, Isaac, Pascual, Juan M., Madden, Christopher J., Mickey, Bruce E., Malloy, Craig M., Bachoo, Robert, Maher, Elizabeth A.“…Mutations in isocitrate dehydrogenase 1 and 2 (IDH1, 2) have been demonstrated in the majority of World Health Organization grade 2 and grade 3 gliomas in adults. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
225
-
226por Van Noorden, Cornelis JFEnlace del recurso
Publicado 2014
Enlace del recurso
Online Artículo Texto -
227“…MiR-181a is able to target isocitrate dehydrogenase 1 (IDH1), a metabolic enzyme in TCA cycle. Via targeting IDH1, miR-181a decreases expression of genes involved in lipid synthesis and increases expression of genes involved in β-oxidation, thereafter inhibiting lipid accumulation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
228por Amelot, Aymeric, De Cremoux, Patricia, Quillien, Véronique, Polivka, Marc, Adle-Biassette, Homa, Lehmann-Che, Jacqueline, Françoise, Laurence, Carpentier, Antoine F., George, Bernard, Mandonnet, Emmanuel, Froelich, Sébastien“…Clinical parameters were obtained from medical records. Mutations of IDH1/2 were analyzed in these patients, by immunohistochemistry for the R132H mutation of IDH1 and by high-resolution melting-curve analysis, followed by Sanger sequencing for IDH1 and IDH2 exon 4 mutations. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
229por Kohanbash, Gary, Shrivastav, Shruti, Ahn, Brian, Hou, Yafei, Costello, Joseph, Okada, HidehoEnlace del recurso
Publicado 2015
Enlace del recurso
Online Artículo Texto -
230por Yang, Pei, Zhang, Wei, Wang, Yinyan, Peng, Xiaoxia, Chen, Baoshi, Qiu, Xiaoguang, Li, Guilin, Li, Shouwei, Wu, Chenxing, Yao, Kun, Li, Wenbin, Yan, Wei, Li, Jie, You, Yongping, Chen, Clark C., Jiang, Tao“…BACKGROUND: The relative contribution of isocitrate dehydrogenase mutations (mIDH) and O6-methylguanine-DNA methyltransferase promoter methylation (methMGMT) as biomarkers in glioblastoma remain poorly understood. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
231“…Randomized controlled trials, and prospective and retrospective studies of patients with glioblastomas that provided IDH mutation and survival data were included. OS and PFS were used to evaluate the association of IDH1 and IDH1/2 mutations and prognosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
232por Koncar, Robert F., Chu, Zhengtao, Romick-Rosendale, Lindsey E., Wells, Susanne I., Chan, Timothy A., Qi, Xiaoyang, Bahassi, El Mustapha“…Up to 90% of grades II-III gliomas contain a single mutant isocitrate dehydrogenase 1 (IDH1) allele. IDH1 mutant-mediated transformation is associated with TMZ resistance; however, there is no clinically available means of sensitizing IDH1 mutant tumors to TMZ. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
233Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profilespor Farshidfar, Farshad, Zheng, Siyuan, Gingras, Marie-Claude, Newton, Yulia, Shih, Juliann, Robertson, A. Gordon, Hinoue, Toshinori, Hoadley, Katherine A., Gibb, Ewan A., Roszik, Jason, Covington, Kyle R., Wu, Chia-Chin, Shinbrot, Eve, Stransky, Nicolas, Hegde, Apurva, Yang, Ju Dong, Reznik, Ed, Sadeghi, Sara, Pedamallu, Chandra Sekhar, Ojesina, Akinyemi I., Hess, Julian M., Auman, J. Todd, Rhie, Suhn K., Bowlby, Reanne, Borad, Mitesh J., Zhu, Andrew X., Stuart, Josh M., Sander, Chris, Akbani, Rehan, Cherniack, Andrew D., Deshpande, Vikram, Mounajjed, Taofic, Foo, Wai Chin, Torbenson, Michael S., Kleiner, David E., Laird, Peter W., Wheeler, David A., McRee, Autumn J., Bathe, Oliver F., Andersen, Jesper B., Bardeesy, Nabeel, Roberts, Lewis R., Kwong, Lawrence N.“…Leveraging the multi-platform data, we observed that ARID1A exhibited DNA hypermethylation and decreased expression in the IDH mutant subtype. More broadly, we found that IDH mutations are associated with an expanded histological spectrum of liver tumors with molecular features that stratify with CCA. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
234por Wang, Peng-Fei, Song, Hong-Wang, Cai, Hong-Qing, Kong, Ling-Wei, Yao, Kun, Jiang, Tao, Li, Shou-Wei, Yan, Chang-Xiang“…NLRs, PLRs, and LMRs were calculated before surgery. IDH mutations were detected immunohistochemically after tumor resection, and patients' clinical outcomes were analyzed after classification into GBM, pGBM, and IDH-wild type glioblastoma (IDH-wt GBM) groups. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
235por White, Karessa, Kim, Mi-Jung, Han, Chul, Park, Hyo-Jin, Ding, Dalian, Boyd, Kevin, Walker, Logan, Linser, Paul, Meneses, Zaimary, Slade, Cole, Hirst, Jonathan, Santostefano, Katherine, Terada, Naohiro, Miyakawa, Takuya, Tanokura, Masaru, Salvi, Richard, Someya, Shinichi“…Isocitrate dehydrogenase (IDH) 2 participates in the TCA cycle and catalyzes the conversion of isocitrate to α-ketoglutarate and NADP(+) to NADPH. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
236por Javadi, Seyed Amirhossein, Hartmann, Christian, Walter, Gerhard Franz, Banan, Roozbeh, Samii, Amir“…The role of isocitrate dehydrogenase 1 (IDH1) mutation in brain stem glioma is not clear. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
237“…IDH2 deficiency also promoted pigmentation on the dorsal skin of mice, as evident from the elevated levels of melanin synthesis markers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
238por Ballester, Leomar Y., Dunbar, Erin, Guha-Thakurta, Nandita, Henson, John W., Chandler, Howard, Watkins, Jeremiah, Fuller, Gregory N.“…Molecular studies demonstrated the presence of IDH1 IDH1 c.395G>A p.R132H and CIC c.601C>T p.R281W mutations and 1p/19q codeletion. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
239por Intlekofer, Andrew M., Shih, Alan H., Wang, Bo, Nazir, Abbas, Rustenburg, Ariën S., Albanese, Steven K., Patel, Minal, Famulare, Christopher, Correa, Fabian M., Takemoto, Naofumi, Durani, Vidushi, Liu, Hui, Taylor, Justin, Farnoud, Noushin, Papaemmanuil, Elli, Cross, Justin R., Tallman, Martin S., Arcila, Maria E., Roshal, Mikhail, Petsko, Gregory A., Wu, Bin, Choe, Sung, Konteatis, Zenon D., Biller, Scott A., Chodera, John D., Thompson, Craig B., Levine, Ross L., Stein, Eytan M.“…Enasidenib (AG-221) is an allosteric inhibitor that binds to the IDH2 dimer interface and blocks 2HG production by IDH2 mutants(9,10). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
240por Dao Trong, Philip, Rösch, Saskia, Mairbäurl, Heimo, Pusch, Stefan, Unterberg, Andreas, Herold-Mende, Christel, Warta, Rolf“…Due to the paucity of cell models of Isocitrate Dehydrogenase 1 mutant (IDH1(mut)) GSCs, biology under hypoxic conditions has not been sufficiently studied as compared to IDH1 wildtype (IDH1(wt)) GSCs. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto